ono 1078 has been researched along with Stroke in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shi, QJ | 1 |
Wang, H | 1 |
Liu, ZX | 1 |
Fang, SH | 1 |
Song, XM | 1 |
Lu, YB | 1 |
Zhang, WP | 1 |
Sa, XY | 1 |
Ying, HZ | 1 |
Wei, EQ | 1 |
1 other study available for ono 1078 and Stroke
Article | Year |
---|---|
HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Topics: Acute Disease; Animals; Brain; Brain Edema; Brain Ischemia; Chromones; Cyclohexanecarboxylic Acids; | 2015 |